LANCL2 and influenza: Moreover, oral administration of ABA as a pre- and post-exposure therapeutic upregulates LANCL2 expression in the lungs of influenza-infected mice, reduces influenza virus-related immunopathology, and accelerates recovery in infected mice (14).